Robert Cavanaugh Biography and Net Worth

President of Accolade


Robert Cavanaugh is responsible for ensuring the company delivers on its promises to customers and members, drives long-term profitable growth and continues to lead the market in Personalized Healthcare. He has supported Accolade through its IPO and managed the incredible organizational growth of Accolade, doubling the number of employees working worldwide to reinvent healthcare.

Cavanaugh formerly served as President, Worldwide Enterprise, SMB and Government at Concur, where he held several leadership positions over his 15+ years. He was formerly Concur’s Executive Vice President of Client Development, Executive Vice President of Business Development, and Senior Director of Client Services. Prior to joining Concur, Cavanaugh served as an officer in the United States Army Reserve from 1991-2000 and holds a Bachelor of Science from Norwich University.

What is Robert N. Cavanaugh's net worth?

The estimated net worth of Robert N. Cavanaugh is at least $1.56 million as of April 2nd, 2025. Mr. Cavanaugh owns 222,216 shares of Accolade stock worth more than $1,559,956 as of December 5th. This net worth evaluation does not reflect any other assets that Mr. Cavanaugh may own. Additionally, Mr. Cavanaugh receives an annual salary of $413,500.00 as President at Accolade. Learn More about Robert N. Cavanaugh's net worth.

How old is Robert N. Cavanaugh?

Mr. Cavanaugh is currently 55 years old. There are 4 older executives and no younger executives at Accolade. The oldest executive at Accolade is Mr. Rajeev Singh, Chairman of the Board & CEO, who is 56 years old. Learn More on Robert N. Cavanaugh's age.

What is Robert N. Cavanaugh's salary?

As the President of Accolade, Inc., Mr. Cavanaugh earns $413,500.00 per year. The highest earning executive at Accolade is Mr. Rajeev Singh, Chairman of the Board & CEO, who commands a salary of $503,500.00 per year. Learn More on Robert N. Cavanaugh's salary.

How do I contact Robert N. Cavanaugh?

The corporate mailing address for Mr. Cavanaugh and other Accolade executives is 660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING PA, 19462. Accolade can also be reached via phone at 206-926-8100 and via email at [email protected]. Learn More on Robert N. Cavanaugh's contact information.

Has Robert N. Cavanaugh been buying or selling shares of Accolade?

Robert N. Cavanaugh has not been actively trading shares of Accolade within the last three months. Most recently, Robert N. Cavanaugh sold 550 shares of the business's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $6.99, for a transaction totalling $3,844.50. Following the completion of the sale, the president now directly owns 222,216 shares of the company's stock, valued at $1,553,289.84. Learn More on Robert N. Cavanaugh's trading history.

Who are Accolade's active insiders?

Accolade's insider roster includes Stephen Barnes (CFO), Robert Cavanaugh (President), Richard Eskew (Executive Vice President, General Counsel, Chief Compliance Officer), and Rajeev Singh (CEO). Learn More on Accolade's active insiders.

Are insiders buying or selling shares of Accolade?

During the last year, insiders at the sold shares 37 times. They sold a total of 16,651 shares worth more than $99,396.52. The most recent insider tranaction occured on April, 2nd when CFO Stephen H Barnes sold 431 shares worth more than $3,012.69. Insiders at Accolade own 8.2% of the company. Learn More about insider trades at Accolade.

Information on this page was last updated on 4/2/2025.

Robert N. Cavanaugh Insider Trading History at Accolade

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/2/2025Sell550$6.99$3,844.50222,216View SEC Filing Icon  
3/18/2025Sell181$6.99$1,265.19218,697View SEC Filing Icon  
3/11/2025Sell249$6.96$1,733.04218,369View SEC Filing Icon  
3/4/2025Sell550$6.96$3,828.00217,908View SEC Filing Icon  
2/11/2025Sell252$6.88$1,733.76216,559View SEC Filing Icon  
2/4/2025Sell557$6.93$3,860.01216,100View SEC Filing Icon  
1/17/2025Sell186$6.86$1,275.96215,089View SEC Filing Icon  
1/13/2025Sell256$6.88$1,761.28214,765View SEC Filing Icon  
1/3/2025Sell553$3.41$1,885.73214,311View SEC Filing Icon  
12/11/2024Sell214$3.62$774.68212,941View SEC Filing Icon  
12/3/2024Sell5,582$3.60$20,095.20212,445View SEC Filing Icon  
11/19/2024Sell154$3.35$515.90199,502View SEC Filing Icon  
11/12/2024Sell214$3.64$778.96199,146View SEC Filing Icon  
11/4/2024Sell475$3.15$1,496.25198,649View SEC Filing Icon  
10/17/2024Sell157$3.67$576.19197,555View SEC Filing Icon  
10/11/2024Sell217$3.77$818.09197,202View SEC Filing Icon  
10/2/2024Sell474$3.70$1,753.80196,709View SEC Filing Icon  
9/17/2024Sell149$4.32$643.68195,615View SEC Filing Icon  
9/11/2024Sell215$3.91$840.65195,254View SEC Filing Icon  
9/4/2024Sell470$4.22$1,983.40194,758View SEC Filing Icon  
8/19/2024Sell153$4.14$633.42193,659View SEC Filing Icon  
8/13/2024Sell213$3.90$830.70193,302View SEC Filing Icon  
8/2/2024Sell491$3.71$1,821.61192,805View SEC Filing Icon  
7/17/2024Sell157$3.86$606.02191,728View SEC Filing Icon  
7/11/2024Sell208$3.52$732.16191,376View SEC Filing Icon  
7/2/2024Sell457$3.54$1,617.78190,874View SEC Filing Icon  
6/11/2024Sell223$6.45$1,438.35176,315View SEC Filing Icon  
5/17/2024Sell154$7.27$1,119.58173,327View SEC Filing Icon  
5/13/2024Sell206$7.44$1,532.64172,971View SEC Filing Icon  
4/18/2024Sell141$8.82$1,243.62172,467View SEC Filing Icon  
4/11/2024Sell253$8.85$2,239.05172,098View SEC Filing Icon  
3/19/2024Sell181$9.48$1,715.88171,640View SEC Filing Icon  
3/12/2024Sell252$9.52$2,399.04171,311View SEC Filing Icon  
2/13/2024Sell268$13.03$3,492.04170,529View SEC Filing Icon  
1/17/2024Sell186$12.86$2,391.96170,086View SEC Filing Icon  
1/11/2024Sell255$14.74$3,758.70169,762View SEC Filing Icon  
12/19/2023Sell151$10.89$1,644.39169,307View SEC Filing Icon  
12/12/2023Sell221$9.23$2,039.83168,948View SEC Filing Icon  
11/17/2023Sell149$7.94$1,183.06168,086View SEC Filing Icon  
11/13/2023Sell217$6.99$1,516.83167,724View SEC Filing Icon  
10/17/2023Sell153$7.22$1,104.66167,231View SEC Filing Icon  
10/11/2023Sell214$8.63$1,846.82166,874View SEC Filing Icon  
9/19/2023Sell157$11.81$1,854.17166,378View SEC Filing Icon  
9/12/2023Sell215$13.23$2,844.45166,025View SEC Filing Icon  
8/18/2023Sell157$13.03$2,045.71165,529View SEC Filing Icon  
8/11/2023Sell217$14.05$3,048.85165,176View SEC Filing Icon  
7/18/2023Sell152$14.16$2,152.32164,683View SEC Filing Icon  
7/11/2023Sell216$12.68$2,738.88164,325View SEC Filing Icon  
6/20/2023Sell157$13.42$2,106.94163,831View SEC Filing Icon  
6/13/2023Sell2,511$13.81$34,676.91163,478View SEC Filing Icon  
5/26/2023Sell712$11.38$8,102.56157,465View SEC Filing Icon  
5/24/2023Sell685$11.82$8,096.70153,930View SEC Filing Icon  
5/22/2023Sell743$10.90$8,098.70147,879View SEC Filing Icon  
5/17/2023Sell150$10.47$1,570.50146,138View SEC Filing Icon  
4/18/2023Sell181$14.58$2,638.98145,778View SEC Filing Icon  
2/17/2023Sell180$11.95$2,151.00145,126View SEC Filing Icon  
1/18/2023Sell176$9.96$1,752.96144,796View SEC Filing Icon  
12/19/2022Sell156$8.43$1,315.08144,462View SEC Filing Icon  
11/17/2022Sell162$8.59$1,391.58144,108View SEC Filing Icon  
10/17/2022Sell146$11.03$1,610.38143,760View SEC Filing Icon  
9/19/2022Sell157$12.27$1,926.39143,396View SEC Filing Icon  
8/17/2022Sell160$12.19$1,950.40143,043View SEC Filing Icon  
7/18/2022Sell150$9.49$1,423.50142,693View SEC Filing Icon  
6/17/2022Sell1,759$5.66$9,955.94142,334View SEC Filing Icon  
See Full Table

Robert N. Cavanaugh Buying and Selling Activity at Accolade

This chart shows Robert N Cavanaugh's buying and selling at Accolade by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Accolade Company Overview

Accolade logo
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.
Read More

Today's Range

Now: $7.02
Low: $7.02
High: $7.02

50 Day Range

MA: $7.02
Low: $7.02
High: $7.02

2 Week Range

Now: $7.02
Low: $3.08
High: $7.03

Volume

N/A

Average Volume

1,482,373 shs

Market Capitalization

$575.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.1